Apitoria Pharma Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ERTUGLIFLOZIN L-PYROGLUTAMIC ACID, with a corresponding US DMF Number 36152.
Remarkably, this DMF maintains an Active status since its submission on August 05, 2021, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 10, 2021, and payment made on August 02, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II